» Authors » Peter A Dargaville

Peter A Dargaville

Explore the profile of Peter A Dargaville including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 109
Citations 1145
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Dargaville P, Herting E, Soll R
Semin Fetal Neonatal Med . 2023 Dec; 28(6):101501. PMID: 38040584
Whilst exogenous surfactant therapy is central to the management of newborn infants with respiratory distress syndrome, its use in other neonatal lung diseases remains inconsistent and controversial. Here we discuss...
12.
Francis K, McKinlay C, Kamlin C, Cheong J, Dargaville P, Dawson J, et al.
Trials . 2023 Nov; 24(1):709. PMID: 37932774
Background: Bronchopulmonary dysplasia (BPD), an inflammatory-mediated chronic lung disease, is common in extremely preterm infants born before 28 weeks' gestation and is associated with an increased risk of adverse neurodevelopmental...
13.
Kribs A, Roberts K, Trevisanuto D, ODonnell C, Dargaville P
Semin Perinatol . 2023 Oct; 47(6):151813. PMID: 37805275
Bronchopulmonary dysplasia (BPD) is one of the most devastating morbidities of preterm infants. Antenatal factors like growth restriction and inflammation are risk factors for its development. Use of oxygen and...
14.
Dargaville P, Kamlin C, Orsini F, Wang X, De Paoli A, Kanmaz Kutman H, et al.
JAMA . 2023 Sep; 330(11):1054-1063. PMID: 37695601
Importance: The long-term effects of surfactant administration via a thin catheter (minimally invasive surfactant therapy [MIST]) in preterm infants with respiratory distress syndrome remain to be definitively clarified. Objective: To...
15.
Marshall A, Ladlow O, Bannink C, Lim K, Ali S, Gale T, et al.
Arch Dis Child Fetal Neonatal Ed . 2023 Aug; 109(1):81-86. PMID: 37640527
Objectives: To investigate the impact of a pre-emptive apnoea triggered oxygen response on oxygen saturation (SpO) targeting following central apnoea in preterm infants. Design: Interventional crossover study of a 12-hour...
16.
Manley B, Kamlin C, Donath S, Huang L, Birch P, Cheong J, et al.
Trials . 2023 May; 24(1):320. PMID: 37161488
Background: Bronchopulmonary dysplasia (BPD), an inflammatory-mediated chronic lung disease, is common in extremely preterm infants born before 28 weeks' gestation and is associated with an increased risk of adverse neurodevelopmental...
17.
Reid E, Kamlin O, Orsini F, De Paoli A, Clark H, Soll R, et al.
Clin Trials . 2023 May; 20(5):479-485. PMID: 37144610
Background: Blinding of treatment allocation from treating clinicians in neonatal randomised controlled trials can minimise performance bias, but its effectiveness is rarely assessed. Methods: To examine the effectiveness of blinding...
18.
Breindahl N, Tolsgaard M, Henriksen T, Roehr C, Szczapa T, Gagliardi L, et al.
Pediatr Res . 2023 May; 94(3):1216-1224. PMID: 37142651
Background: Training and assessment of operator competence for the less invasive surfactant administration (LISA) procedure vary. This study aimed to obtain international expert consensus on LISA training (LISA curriculum (LISA-CUR))...
19.
Eastwood-Sutherland C, Lim K, Gale T, Wheeler K, Dargaville P
Pediatr Pulmonol . 2023 Apr; 58(6):1753-1760. PMID: 37014150
Objective: To examine the effectiveness of a noncontact vision-based infrared respiratory monitor (IRM) in the detection of authentic respiratory motion in newborn infants. Study Design: Observational study in a neonatal...
20.
Cripps E, Dargaville P, De Paoli A
J Paediatr Child Health . 2023 Mar; 59(5):760-765. PMID: 36988230
Aim: To examine the effect of probiotic administration on the incidence of necrotising enterocolitis (NEC) in preterm infants. Methods: We conducted a retrospective study examining the incidence of NEC in...